Jon Kuwahara - See Remarks, Novus Therapeutics, Inc

As of September 15, 2020


Jon Kuwahara Net Worth

  • Net worth is estimated to be at least $21.95K
  • Owns at least 5,974 units of Novus Therapeutics, Inc stock
  • Sold an estimated value of $10.3K in the last 3 years at Novus Therapeutics, Inc

Jon Kuwahara Trading

  • Largest sale of shares was 5,276 units , worth over $10.3K on May 22, 2019
  • In total has made about 7 transactions over 3 years
  • Usually trades in March, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jon Kuwahara Mailing Address

  • Mailing address is 21250 Hawthorne Boulevard Suite 800 Torrance CA 90503 CA

Novus Therapeutics, Inc Insider Trading

  • The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
  • In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
  • The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
  • Insider trading is most common in May, with the busiest year in 2019

Eledon Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1